As of 2024-12-11, the Relative Valuation of HOOKIPA Pharma Inc (HOOK) is (100.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.41 USD, the upside of HOOKIPA Pharma Inc based on Relative Valuation is -4251.8%.
The range of the Relative Valuation is (102.07) - (113.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.4x - 45.2x | 35.0x |
| Forward P/E multiples | 19.9x - 31.5x | 20.6x |
| Fair Price | (102.07) - (113.30) | (100.06) |
| Upside | -4335.5% - -4801.4% | -4251.8% |
| Date | P/E |
| 2024-11-26 | -0.64 |
| 2024-11-25 | -0.63 |
| 2024-11-22 | -0.60 |
| 2024-11-21 | -0.64 |
| 2024-11-20 | -0.76 |
| 2024-11-19 | -0.78 |
| 2024-11-18 | -0.78 |
| 2024-11-15 | -0.83 |
| 2024-11-14 | -0.87 |
| 2024-11-13 | -0.95 |
| 2024-11-12 | -1.00 |
| 2024-11-11 | -1.03 |
| 2024-11-08 | -1.04 |
| 2024-11-07 | -1.03 |
| 2024-11-06 | -1.07 |
| 2024-11-05 | -1.06 |
| 2024-11-04 | -1.04 |
| 2024-11-01 | -1.07 |
| 2024-10-31 | -1.05 |
| 2024-10-30 | -1.07 |
| 2024-10-29 | -1.04 |
| 2024-10-28 | -1.06 |
| 2024-10-25 | -1.05 |
| 2024-10-24 | -1.09 |
| 2024-10-23 | -1.07 |
| 2024-10-22 | -1.11 |
| 2024-10-21 | -1.11 |
| 2024-10-18 | -1.14 |
| 2024-10-17 | -1.16 |
| 2024-10-16 | -1.08 |
| 2024-10-15 | -1.01 |
| 2024-10-14 | -1.03 |
| 2024-10-11 | -1.03 |
| 2024-10-10 | -1.08 |
| 2024-10-09 | -1.06 |
| 2024-10-08 | -1.09 |
| 2024-10-07 | -1.12 |
| 2024-10-04 | -1.13 |
| 2024-10-03 | -1.14 |
| 2024-10-02 | -1.13 |
| 2024-10-01 | -1.13 |
| 2024-09-30 | -1.19 |
| 2024-09-27 | -1.18 |
| 2024-09-26 | -1.16 |
| 2024-09-25 | -1.18 |
| 2024-09-24 | -1.25 |
| 2024-09-23 | -1.27 |
| 2024-09-20 | -1.32 |
| 2024-09-19 | -1.31 |
| 2024-09-18 | -1.28 |